Login
Home
Charts
Search
Watchlist
Products

Dai-ichi Karkaria Ltd

DAICHI·BSE
337.95+3.03%Thu, 24 Sept '26

Dai-ichi Karkaria Ltd

DAICHI
BSE
337.95
+3.03%
|Thu, 24 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
252Cr
Close
Close Price
337.95
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
116.53
PS
Price To Sales
1.40
Revenue
Revenue
180Cr
Rev Gr TTM
Revenue Growth TTM
-3.89%
PAT Gr TTM
PAT Growth TTM
-111.62%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
353533343741703943384158
Growth YoY
Revenue Growth YoY%
-35.5-27.8-21.321.54.815.4109.816.516.4-7.1-41.146.6
Expenses
ExpensesCr
333331323538623841384152
Operating Profit
Operating ProfitCr
223223812016
OPM
OPM%
4.77.08.35.74.76.711.53.24.2-0.81.610.4
Other Income
Other IncomeCr
2111113112111
Interest Expense
Interest ExpenseCr
100010000000
Depreciation
DepreciationCr
222233333333
PBT
PBTCr
20010037-11-2-14
Tax
TaxCr
500001201-102
PAT
PATCr
15110025-10-2-12
Growth YoY
PAT Growth YoY%
21.4-93.4317.490.8-102.5223.7391.0-88.98.1-178.5-118.1500.0
NPM
NPM%
42.31.73.0-0.8-1.04.77.0-1.3-0.8-4.0-2.23.5
EPS
EPS
19.61.51.50.6-0.33.58.30.00.0-1.10.13.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
353533343741703943384158
Growth YoY
Revenue Growth YoY%
-35.5-27.8-21.321.54.815.4109.816.516.4-7.1-41.146.6
Expenses
ExpensesCr
333331323538623841384152
Operating Profit
Operating ProfitCr
223223812016
OPM
OPM%
4.77.08.35.74.76.711.53.24.2-0.81.610.4
Other Income
Other IncomeCr
2111113112111
Interest Expense
Interest ExpenseCr
100010000000
Depreciation
DepreciationCr
222233333333
PBT
PBTCr
20010037-11-2-14
Tax
TaxCr
500001201-102
PAT
PATCr
15110025-10-2-12
Growth YoY
PAT Growth YoY%
21.4-93.4317.490.8-102.5223.7391.0-88.98.1-178.5-118.1500.0
NPM
NPM%
42.31.73.0-0.8-1.04.77.0-1.3-0.8-4.0-2.23.5
EPS
EPS
19.61.51.50.6-0.33.58.30.00.0-1.10.13.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1941261479210797122184132181161180
Growth
Revenue Growth%
7.1-35.016.6-37.116.1-9.125.151.0-28.537.9-11.1-3.9
Expenses
ExpensesCr
162109132103112111140168125167158172
Operating Profit
Operating ProfitCr
321715-11-5-14-181661438
OPM
OPM%
16.613.910.4-11.7-4.7-13.9-15.18.64.88.02.14.5
Other Income
Other IncomeCr
4126208781724645
Interest Expense
Interest ExpenseCr
0007109133211
Depreciation
DepreciationCr
224899779101010
PBT
PBTCr
342716-24-2556-1822188-32
Tax
TaxCr
1274-1207045203
PAT
PATCr
222112-13-2548-1818136-3-1
Growth
PAT Growth%
-6.1-4.5-42.6-205.4-97.5294.2-137.7201.1-27.0-54.2-152.4-111.6
NPM
NPM%
11.316.68.2-13.7-23.349.7-15.010.010.33.4-2.0-0.4
EPS
EPS
29.333.418.4-16.9-30.868.0-24.226.918.612.1-1.02.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1941261479210797122184132181161180
Growth
Revenue Growth%
7.1-35.016.6-37.116.1-9.125.151.0-28.537.9-11.1-3.9
Expenses
ExpensesCr
162109132103112111140168125167158172
Operating Profit
Operating ProfitCr
321715-11-5-14-181661438
OPM
OPM%
16.613.910.4-11.7-4.7-13.9-15.18.64.88.02.14.5
Other Income
Other IncomeCr
4126208781724645
Interest Expense
Interest ExpenseCr
0007109133211
Depreciation
DepreciationCr
224899779101010
PBT
PBTCr
342716-24-2556-1822188-32
Tax
TaxCr
1274-1207045203
PAT
PATCr
222112-13-2548-1818136-3-1
Growth
PAT Growth%
-6.1-4.5-42.6-205.4-97.5294.2-137.7201.1-27.0-54.2-152.4-111.6
NPM
NPM%
11.316.68.2-13.7-23.349.7-15.010.010.33.4-2.0-0.4
EPS
EPS
29.333.418.4-16.9-30.868.0-24.226.918.612.1-1.02.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
119142151135112163142162173181177
Current Liabilities
Current LiabilitiesCr
3023546480665858394236
Non Current Liabilities
Non Current LiabilitiesCr
266375702720333
Total Liabilities
Total LiabilitiesCr
159179276281270239214247222232224
Current Assets
Current AssetsCr
106911007274936868537065
Non Current Assets
Non Current AssetsCr
5488176209196146146179169162159
Total Assets
Total AssetsCr
159179276281270239214247222232224
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
119142151135112163142162173181177
Current Liabilities
Current LiabilitiesCr
3023546480665858394236
Non Current Liabilities
Non Current LiabilitiesCr
266375702720333
Total Liabilities
Total LiabilitiesCr
159179276281270239214247222232224
Current Assets
Current AssetsCr
106911007274936868537065
Non Current Assets
Non Current AssetsCr
5488176209196146146179169162159
Total Assets
Total AssetsCr
159179276281270239214247222232224

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
113-861-22-32310165
Investing Cash Flow
Investing Cash FlowCr
-8-7-57-211130-4-3316-4-10
Financing Cash Flow
Financing Cash FlowCr
-626616-6-97-213-25-10-3
Net Cash Flow
Net Cash FlowCr
-3-222-411-10413-8
Free Cash Flow
Free Cash FlowCr
0-19-90-32-1109-14-10514-4
CFO To PAT
CFO To PAT%
50.312.4-64.9-49.3-3.9-44.518.7125.574.6260.8-159.9
CFO To EBITDA
CFO To EBITDA%
34.314.9-51.0-57.5-18.9159.018.6145.9159.9111.5149.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
113-861-22-32310165
Investing Cash Flow
Investing Cash FlowCr
-8-7-57-211130-4-3316-4-10
Financing Cash Flow
Financing Cash FlowCr
-626616-6-97-213-25-10-3
Net Cash Flow
Net Cash FlowCr
-3-222-411-10413-8
Free Cash Flow
Free Cash FlowCr
0-19-90-32-1109-14-10514-4
CFO To PAT
CFO To PAT%
50.312.4-64.9-49.3-3.9-44.518.7125.574.6260.8-159.9
CFO To EBITDA
CFO To EBITDA%
34.314.9-51.0-57.5-18.9159.018.6145.9159.9111.5149.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
260370295153130222272270380177166252
Price To Earnings
Price To Earnings
12.814.821.64.413.427.419.7116.5
Price To Sales
Price To Sales
1.32.92.01.71.22.32.21.52.91.01.01.4
Price To Book
Price To Book
2.12.51.91.11.11.31.81.62.10.90.91.4
EV To EBITDA
EV To EBITDA
7.821.123.5-21.6-42.9-16.7-15.718.962.512.450.930.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.833.429.419.923.314.814.228.230.228.225.525.5
OPM
OPM%
16.613.910.4-11.7-4.7-13.9-15.18.64.88.02.14.5
NPM
NPM%
11.316.68.2-13.7-23.349.7-15.010.010.33.4-2.0-0.4
ROCE
ROCE%
26.718.07.2-7.5-7.034.1-9.812.110.75.1-1.1-1.1
ROE
ROE%
17.313.97.5-8.8-20.828.4-12.210.97.53.3-1.8-1.8
ROA
ROA%
13.711.74.3-4.5-9.220.3-8.57.56.12.7-1.4-1.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
260370295153130222272270380177166252
Price To Earnings
Price To Earnings
12.814.821.64.413.427.419.7116.5
Price To Sales
Price To Sales
1.32.92.01.71.22.32.21.52.91.01.01.4
Price To Book
Price To Book
2.12.51.91.11.11.31.81.62.10.90.91.4
EV To EBITDA
EV To EBITDA
7.821.123.5-21.6-42.9-16.7-15.718.962.512.450.930.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.833.429.419.923.314.814.228.230.228.225.525.5
OPM
OPM%
16.613.910.4-11.7-4.7-13.9-15.18.64.88.02.14.5
NPM
NPM%
11.316.68.2-13.7-23.349.7-15.010.010.33.4-2.0-0.4
ROCE
ROCE%
26.718.07.2-7.5-7.034.1-9.812.110.75.1-1.1-1.1
ROE
ROE%
17.313.97.5-8.8-20.828.4-12.210.97.53.3-1.8-1.8
ROA
ROA%
13.711.74.3-4.5-9.220.3-8.57.56.12.7-1.4-1.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Dai-ichi Karkaria is a specialty chemicals maker that designs high-performance ingredients for other manufacturers - it does not sell branded products to consumers but solves specific industrial problems, from keeping crude oil flowing through pipelines to making pesticide sprays stick to leaves. It began production in 1963 in a technical partnership with Japan’s Dai-ichi Kogyo Seiyaku, and its entire history runs on the same engine: spotting a performance gap in an Indian industry, developing the first domestic solution - it created India’s first demulsifier for ONGC in 1967 and the first pour point depressant in 1980 - and then building a customer relationship that lasts decades. That approach, repeated across oilfields, agrochemicals, paints, personal care and textiles, has produced a single integrated specialty chemicals platform where the same reactors, the same chemistries and the same R&D team serve multiple end markets, and where every new molecule is co-developed with the customer who will use it. # Business segments One integrated specialty chemicals engine serving five distinct end markets - oilfield, agrochemicals, home and personal care, paints and coatings, and textiles - all running on the same manufacturing backbone and the same customer-driven innovation model. ## 1. Oilfield chemicals: the original moat **The company makes additives that keep crude oil flowing through pipelines and refineries - a business built on India-first inventions and deep-water technical approvals that competitors find hard to replicate.** - **Invented the category in India** - it developed the country’s first demulsifier for ONGC in 1967 and the first pour point depressant (PPD) in 1980, giving it a multi-decade head start in customer relationships and field-proven formulations. - **Solves the hardest flow problems** - its products include PPDs for crude blends, viscosity improvers, asphaltene dispersants, and corrosion inhibitor intermediates, with a recent breakthrough in a key deep-water PPD application for one of its largest customers. - **Exports drive the order book in the Oilfield vertical** - volumes have grown on the back of international demand, reactivated dormant accounts, and new chemical technologies, with key accounts in the Middle East and North Africa and new distributor agreements being signed in global markets. - **Seasonal but sticky** - demand concentrates in the last two quarters of the financial year, but the company generally holds a good order book and supplies its joint venture, ChampionX Dai-ichi India, as a related-party customer in the ordinary course of business. ## 2. Agrochemicals: the formulation partner **It makes the emulsifiers and dispersing agents that turn pesticide active ingredients into sprayable, stable products - and it is riding the industry’s shift toward water-based formulations.** - **Formulation shift creates demand** - the industry is moving from solvent-based emulsifiable concentrates to water-based suspension concentrates, emulsions in water, and capsule suspensions, and the company develops surfactants specifically for these novel formats. - **Import substitution at work** - it developed specialty surfactants for suspension concentrate formulations that won approval from key customers, replacing imports with locally made alternatives. - **Beyond its own plant** - the company also performs third-party manufacturing of dispersants for wettable powders and water-dispersible granules in the agrochemical segment, adding revenue without tying up its own reactor capacity. ## 3. Home and personal care: the purity play **It supplies solubilizers, surfactants and conditioning agents that go into shampoos, lotions and cleaning products - competing on high-purity ingredients that meet strict global regulatory standards.** - **Regulatory compliance as a differentiator** - the company can produce ingredients with almost zero free ethylene oxide, using an in-house process and Swiss Buss Technology to meet the EU norm of less than 0.2 parts per million, and it holds Kosher and Halal certifications for this segment. - **Natural extracts are a growth pocket** - its oleoresin solubilizer, which meets stringent global specifications, grew roughly 50% in volume in one year, and it developed biodegradable surfactants and EO-free emulsifiers for natural extract formulations. - **Distributors open new geographies** - the company has appointed distributors in new markets for its Home and Personal Care segment to expand its reach, though competition has increased with more suppliers entering and driving price pressure. ## 4. Paints and coatings: the green-formulation supplier **It provides surfactants and dispersing agents to almost every major paint manufacturer in India, with a growing line of low-VOC and APEO-free products.** - **Supplies the whole industry** - the company sells to nearly all the major paint players in India, making this a broad-based domestic franchise. - **Import substitution in fluids** - sales of an import-substitute EO-PO based fluid more than doubled in both volume and value in a single year, showing the pull for locally developed alternatives. ## 5. Textile auxiliaries and flocculants: the steady contributors **These smaller, mature segments supply chemicals for fabric processing and water treatment - stable businesses with long-standing customer ties.** - **Textile chemicals from pre-treatment to finish** - the portfolio includes surfactants, dispersing agents, softeners and a newly developed antistatic additive for polyester staple fibres, with new customer engagements beginning in the last quarter of FY25. - **Rayon and sizing niches** - the company supplies all major rayon producers in India and saw 80% growth in rayon chemicals when demand for viscose fabrics resumed; its sizing chemicals business registered 45% growth with a breakthrough at a major Surat unit, though it faces competition from Taiwanese suppliers. - **Flocculants for industrial processing** - it provides flocculants to the paper, sugar and mining industries from a plant in Kurkumbh commissioned in 1995, serving as a stable, low-volatility contributor. # Manufacturing backbone **Two plants - Dahej in Gujarat and Kurkumbh in Maharashtra - run a shared set of chemical reactions that serve every end market, with ethoxylation capacity near full utilisation and expansion underway.** - **One reaction toolkit, many products** - the manufacturing platform is built on ethoxylation, propoxylation, esterification, polymerisation, quaternisation, phosphorylation, sulfation and sulfosuccination, so the same reactors can produce surfactants for agrochemicals, personal care, oilfield and paints. - **Ethoxylation is the bottleneck and the growth lever** - the existing alkoxylation unit runs at roughly 95% utilisation of its approximately 5,000-tonne annual capacity; an additional 5,000 tonnes per annum is being added with a Rs. 10 crore investment, funded from internal accruals, for commissioning in the fourth quarter of FY26. - **Rebuilt after fire, stronger than before** - a fire at Dahej in November 2020 destroyed key machinery, but the company kept customers supplied through five outsourcing sites within a short period, then rebuilt the plant in phases using internal accruals and a term loan, restoring and then expanding capacity. - **Speed and efficiency gains** - lab turnaround times on high-volume products were cut by up to 50%, AI is used for predictive maintenance and batch-data analysis to reduce cycle times, and the Dahej facility hit record monthly output across key product lines. # Group structure and partners **A family-run company with a 50:50 oilfield joint venture that is also a major customer, a wholly owned subsidiary, and a related-party raw material supplier - creating an interlinked structure where the company sells to entities it partly owns.** - **ChampionX Dai-ichi India (CXDI)** - a 50:50 joint venture formed in 2009 with Champion Technologies (now ChampionX) for the Indian oilfield upstream chemical sector; both partners supply raw materials to CXDI, and the company sells goods to CXDI at arm’s length, with related-party sales estimated at up to Rs. 50 crore. - **Dai-ichi Goseichemicals (India)** - a wholly owned subsidiary. - **Indian Oxides and Chemicals (IOCL)** - a related party that supplies metal oxides as raw materials at competitive market prices, with purchases expected to cross the Rs. 18.13 crore materiality threshold; the company’s Chairperson, Mrs. Shernaz Vakil, is a director of both CXDI and IOCL. - **Family leadership** - Mrs. Shernaz Vakil serves as Chairperson and Managing Director, while her daughter Ms. Meher Vakil is Whole-time Director and COO, holding a BA in Economics and Business from Northwestern University.

Documents — Dai-ichi Karkaria Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/kk4rt1j4wmvs0urhniywfrr3.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/2qtohuorhatztxhd922khr5n.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/xyl41pcg80bazzj39i3c2u77.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/gvnmu1y1faxma7d1hy494txr.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/n0yjb2ol4b8za6kvnhkqm86o.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/x1can5twot2403qyyp2hrsdr.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/iks7cejfk2jgw05vtn0ccpmn.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/eq6j6i2albriqdrllxhc9qxm.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/4zsd5byxp338fd13yvssfykq.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/jvmt33pqoqjk21hb6ffw9saa.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/oq7fzjtnvsgybj9f27k5sg1v.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/zmm4bo9xy387x929nscds5fx.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/7rqslauldm47mp47zc96qxl4.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/j6l4qg2dac9acwr3r1r4ix81.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/y3qaaq8v4rrnppssqtbsw2wx.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/5bzvpe4z8dc9a4eniylyqi8l.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/j8rnk9licmiuzb3ddkiiviag.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/tgrd0q36k1849vepj6lsh4w0.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/8296qjcsp0ih6tns14mu2w3l.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4tkzmwygd5vr4std89sq97zy.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/3t0mt71vdh7pd1s0e414dx4q.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/csigyiyljpu98cf0waqa6d6n.pdf